Daily Roundup

RMD.ASX ALK.ASX FRS.ASX ALX.ASX CGS.ASX

Resmed to Divest MatrixCare Business for $490 Million

Resmed Inc. is selling its MatrixCare business to Frazier Healthcare Partners for $490 million in cash, marking a strategic shift toward high-growth opportunities. The company plans to use the proceeds for share repurchases and general corporate purposes, with the deal expected to close in Q1 of fiscal year 2027, pending regulatory approvals. MatrixCare currently serves over 15,000 providers with software solutions and will continue operating under Resmed until the transaction completes. The company will provide its full fiscal year 2027 outlook during its fourth quarter earnings call on August 6, 2026.

Gold Producers Report Strong Results

Alkane Resources Ltd has hit the top half of its FY2026 production guidance, producing 42,491 ounces of gold equivalent in the latest quarter and 168,337 oz AuEq year-to-date. The company's cash, bullion, and listed investments balance jumped $104 million to $454 million, reflecting a strengthened financial position heading into the second half of the year. Managing Director & CEO Nic Earner highlighted the solid production performance and robust balance sheet as the company tracks toward its full-year guidance range of 160,000 to 175,000 ounces equivalent.

Forrestania-Zenith Merger Moves Forward

In related mining news, Zenith Minerals' Board has unanimously recommended shareholders accept Forrestania Resources' off-market takeover offer, which provides a 4.4% premium over recent trading prices. The recommendation comes after Forrestania's acquisition of the Edna May Gold Hub and a successful $310 million capital raising, strengthening the combined entity's prospects. Under the offer, Zenith shareholders will receive one new Forrestania share for every 4.3 Zenith shares held. Shareholders have until July 31, 2026 to accept the offer, with no superior proposals having emerged to date.

Atlas Arteria Takeover Concludes

Atlas Arteria Limited announced the close of the IFM Takeover Offer on July 7, 2026, with Diamond Infraco 1 Pty Ltd, a subsidiary of IFM Global Infrastructure Fund, now holding 67.43% voting power. Debbie Goodin has been re-elected as Independent Non-executive Chair, while John Wigglesworth was appointed Interim Chair of Atlas Arteria Limited. The boards are currently identifying a new Independent Chair for the company.

Cogstate Enters New Year With Record Momentum

Cogstate Ltd capped off a banner year with record net sales contracts of $89.0 million in FY26, more than doubling the prior year's $41.3 million. The company enters FY27 with $118.5 million in contracted future revenue—a 32% increase year-over-year—with $48.3 million expected to be recognized as revenue in the coming year. Clinical Trials revenue is particularly strong, with contracted FY27 revenue of $46.1 million representing a 58% jump from $29.2 million a year earlier. Healthcare revenue remains flat at $2.3 million for FY27.